These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33323763)

  • 1. What providers need to know about progestogens in hormone therapy.
    Liu JH
    Menopause; 2020 Dec; 28(3):325-326. PubMed ID: 33323763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micronized progesterone and its impact on the endometrium and breast vs. progestogens.
    Gompel A
    Climacteric; 2012 Apr; 15 Suppl 1():18-25. PubMed ID: 22432812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Progestogens in Menopausal Hormone Therapy.
    Liu JH
    Clin Obstet Gynecol; 2021 Dec; 64(4):772-783. PubMed ID: 34593694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone, progestins and the endometrium in perimenopause and in menopausal hormone therapy.
    Gompel A
    Climacteric; 2018 Aug; 21(4):321-325. PubMed ID: 29583028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
    Illouz S; Dales JP; Sferlazzo K; Garcia S; Carpentier-Meunier S; Boubli L; Lavaut MN; Charpin C
    Int J Mol Med; 2003 Oct; 12(4):517-23. PubMed ID: 12964029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of progesterone and progestins on endometrial proliferation.
    Moyer DL; Felix JC
    Contraception; 1998 Jun; 57(6):399-403. PubMed ID: 9693400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial.
    Lindenfeld EA; Langer RD
    Obstet Gynecol; 2002 Nov; 100(5 Pt 1):853-63. PubMed ID: 12423841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for hormone replacement therapy in atherosclerosis prevention.
    Wagner JD
    J Reprod Med; 2000 Mar; 45(3 Suppl):245-58. PubMed ID: 10756506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial.
    MacLennan AH; MacLennan A; Wenzel S; Chambers HM; Eckert K
    Med J Aust; 1993 Jul; 159(2):102-6. PubMed ID: 8336583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone.
    Shulman LP
    J Womens Health (Larchmt); 2006 Jun; 15(5):584-90. PubMed ID: 16796485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone and endometrial cancer.
    Gompel A
    Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():95-107. PubMed ID: 32732107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestogen safety and tolerance in hormonal replacement therapy.
    Palacios S; Mejía A
    Expert Opin Drug Saf; 2016 Nov; 15(11):1515-1525. PubMed ID: 27548404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells.
    Ruan X; Neubauer H; Yang Y; Schneck H; Schultz S; Fehm T; Cahill MA; Seeger H; Mueck AO
    Climacteric; 2012 Oct; 15(5):467-72. PubMed ID: 22335423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
    Mueck AO; Seeger H; Wallwiener D
    Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of oestrogens and progestogens.
    Lauritzen C
    Maturitas; 1990 Sep; 12(3):199-214. PubMed ID: 2215269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on estradiol dehydrogenase activity in the human uterine endometrium].
    Kitawaki J
    Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):894-912. PubMed ID: 2960569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of micronized progesterone on the endometrium: a systematic review.
    Stute P; Neulen J; Wildt L
    Climacteric; 2016 Aug; 19(4):316-28. PubMed ID: 27277331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestins initiate adverse events of menopausal estrogen therapy.
    Thomas T; Rhodin J; Clark L; Garces A
    Climacteric; 2003 Dec; 6(4):293-301. PubMed ID: 15011717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.